The number three is a powerful guide to formulating slogans, statements of principles, and story telling in all walks of life, including medicine. The statistical rule of three states that the 95 confidence interval of a zero observation is 0–3, so that if you don’t see a particular outcome, such as an adverse reaction, in a clinical trial of an intervention, there is still a chance that it will occur when the intervention is used more widely; thus, if an event is not seen in a study of 100 individuals there is up to a 3% chance of seeing it in practice; if it isn’t seen in 1000 individuals the chance of seeing it subsequently is up to 0.3% and so on. Triadic medical slogans include “see one, do one, teach one”; “history, examination, investigation”; and “percussion, palpation, auscultation.” There is a rule of three that has been applied to fragment-based drug discovery, and the triad that informs subsequent drug development is “quality, efficacy, safety,” although not necessarily in that order. Most clinical syndromes have at least three components, although there are a few with only one or two.I have previously discussed the power that the number three has as a guide in formulating slogans, statements of principles, and story telling.1 Here I concentrate on some of the medical relevance of triads.The term “rule of three” has often been used to describe the principle of concatenating triplets when creating slogans, for example in advertising and other activities.2 However, the most important rule of three, relevant to medicine, is a statistical one,3 as an example shows.If you treat 100 people with an intervention and log all the adverse events that occur, there are many adverse events that never occur. Suppose during a study of an …
Jeffrey K Aronson's articles primarily focus on healthcare and pharmaceutical regulation, with a specific emphasis on medical terminology and language. He also covers legal policy regulations related to the pharmaceutical industry.
Given his focus, Jeffrey is more likely to be interested in expert commentary from professionals well-versed in medical terminology, pharmacology, or linguistic experts who can provide insights into the evolution of medical language or its regulatory aspects. Additionally, professionals knowledgeable about specific legal policies regarding medicines regulation may find success when reaching out to him for potential collaboration.










